Latest Headlines

  1. Andelyn Biosciences To Scale Manufacturing For Genprex's Diabetes Gene Therapy Program 9/1/2026
  2. AST Names Industry Veteran Jon Lenihan As Chief Commercial Officer 8/31/2026
  3. JHS And Altoura Selected For BioTools Innovator VANGUARD Level Up-XR Program 8/28/2026

    Jubilant HollisterStier(JHS) and Altoura will be of only three company-CDMO pairs participating in the BioTools Innovator VANGUARD Level Up-XR Program.

  4. Resilience And Lilly Invest $750 Million To Increase U.S.-Manufactured Medicine Supply 8/28/2026
  5. AES Cleanroom Technology Panels Earn FM 4882 Approval, Addressing The Cleanroom Risk That Fire Ratings Miss 8/27/2026
  6. UCB Selects Gwinnett County For New U.S. Biologics Manufacturing Facility 8/20/2026

    UCB today announced that it has selected Gwinnett County, Georgia as the location for its new U.S. biologics manufacturing facility. The campus will be state-of-the art, using a digital-first approach by leveraging AI, robotics, and automation while being natural resources efficient. The project represents a major milestone in UCB’s previously announced U.S. expansion and reinforces the company’s long-term commitment to patients, innovation, and sustainable growth in one of its fastest-growing markets.

  7. Nordson MEDICAL Introduces The New Divert™ ULTRA Line Of Ultra-High- Pressure Stopcocks For Demanding Medical Applications 8/19/2026

    Nordson MEDICAL introduces Divert™ ULTRA, ultra-high-pressure stopcocks engineered for reliable flow control, ergonomic operation, and precision in demanding medical applications up to 1,500 psi.

  8. New Distek Software Simplifies Bioreactor Data Monitoring And Management 8/12/2026

    Distek, Inc., a leading manufacturer of bioprocessing equipment, announces the release of their BIOne Core Software, an advanced, cloud-based historian software platform designed exclusively for BIOne Bioprocess Controllers. Delivered as a Software-as-a-Service (SaaS) solution, BIOne Core enables users to easily visualize, monitor, and manage critical bioprocess data while minimizing on-premise IT infrastructure.

  9. ILC Dover Introduces EZJetFlo™ Technology To Transform Powder Dissolution And Mixing In Biopharmaceutical Manufacturing 8/7/2026
  10. Tasrif Pharmaceutical Granted Second U.S. Patent For CD155-Targeting Antibody Developed With Abzena's Humanization & Immunogenicity Platforms 7/31/2026

    On July 29, 2026, Abzen’s customer Tasrif Pharmaceutical, LLC announced the grant of its second U.S. Patent, expanding its intellectual property targeting the Poliovirus Receptor (CD155/PVR).